New Era of Immunotherapy in Pediatric Brain Tumors: Chimeric Antigen Receptor T-Cell Therapy

Immunotherapy, including chimeric antigen receptor (CAR) T-cell therapy, immune checkpoint inhibitors, cancer vaccines, and dendritic cell therapy, has been incorporated as a fifth modality of modern cancer care, along with surgery, radiation, chemotherapy, and target therapy. Among them, CAR T-cell...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Wan-Tai, Lin, Wen-Ying, Chen, Yi-Wei, Lin, Chun-Fu, Wang, Hsin-Hui, Wu, Szu-Hsien, Lee, Yi-Yen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7957810/
https://www.ncbi.nlm.nih.gov/pubmed/33673696
http://dx.doi.org/10.3390/ijms22052404

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7957810/
https://www.ncbi.nlm.nih.gov/pubmed/33673696
http://dx.doi.org/10.3390/ijms22052404

Ejemplares similares